Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors
- PMID: 19936286
- PMCID: PMC2779351
- DOI: 10.2174/157340308784245775
Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors
Abstract
Atherosclerosis is a chronic inflammatory disorder characterized by immune cell activation, inflammation driven plaque formation and subsequent destabilization. In other disorders of an inflammatory nature, the chronic inflammatory state per se has been linked to acceleration of the atherosclerotic process which is underlined by an increased incidence of cardiovascular disease (CVD) in disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and antiphopholipid (Hughes) syndrome (APS). SLE is an autoimmune disease that may affect any organ. Premature coronary heart disease has emerged as a major cause of morbidity and mortality in SLE. In addition to mortality, cardiovascular morbidity is also markedly increased in these patients, compared with the general population. The increased cardiovascular risk can be explained only partially by an increased prevalence of classical risk factors for cardiovascular disease; it also appears to be related to inflammation. Inflammation is increasingly being considered central to the pathogenesis of atherosclerosis and an important risk factor for vascular disease. Recent epidemiologic and pathogenesis studies have suggested a great deal in common between the pathogenesis of prototypic autoimmune disease such as SLE and that of atherosclerosis.We will review traditional risk factors for CVD in SLE. We will also discuss the role of inflammation in atherosclerosis, as well as possible treatment strategies in these patients.
Keywords: Cardiovascular disease; atherosclerosis; systemic lupus erythematosus.
Similar articles
-
Atherogenesis in rheumatology.Lupus. 2006;15(3):117-21. doi: 10.1191/0961203306lu2273rr. Lupus. 2006. PMID: 16634362 Review.
-
Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.Autoimmun Rev. 2006 May;5(5):331-7. doi: 10.1016/j.autrev.2005.12.006. Epub 2006 Feb 3. Autoimmun Rev. 2006. PMID: 16782558 Review.
-
[Atherosclerosis in systemic lupus erythematosus].Presse Med. 2014 Oct;43(10 Pt 1):1034-47. doi: 10.1016/j.lpm.2014.01.021. Epub 2014 Sep 5. Presse Med. 2014. PMID: 25201598 Review. French.
-
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.Rheumatology (Oxford). 2005 Dec;44(12):1492-502. doi: 10.1093/rheumatology/kei142. Epub 2005 Oct 18. Rheumatology (Oxford). 2005. PMID: 16234277 Review.
-
[Accelerated atherosclerosis and inflammation in systemic lupus erythematosus].Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(6):470-80. doi: 10.2177/jsci.35.470. Nihon Rinsho Meneki Gakkai Kaishi. 2012. PMID: 23291482 Review. Japanese.
Cited by
-
Traditional and Emerging Sex-Specific Risk Factors for Cardiovascular Disease in Women.Rev Cardiovasc Med. 2022 Aug 16;23(8):288. doi: 10.31083/j.rcm2308288. eCollection 2022 Aug. Rev Cardiovasc Med. 2022. PMID: 39076638 Free PMC article. Review.
-
Cardiovascular Morbidity in Systemic Lupus Erythematosus: A Single-Center Retrospective Study.Cureus. 2024 Apr 8;16(4):e57842. doi: 10.7759/cureus.57842. eCollection 2024 Apr. Cureus. 2024. PMID: 38721162 Free PMC article.
-
Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis.Lupus Sci Med. 2024 Mar 21;11(1):e001152. doi: 10.1136/lupus-2024-001152. Lupus Sci Med. 2024. PMID: 38519060 Free PMC article.
-
Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician.Immunotargets Ther. 2023 Dec 8;12:175-186. doi: 10.2147/ITT.S377076. eCollection 2023. Immunotargets Ther. 2023. PMID: 38089168 Free PMC article. Review.
-
Computed Tomography (CT) Calcium Scoring in Primary Prevention of Acute Coronary Syndrome and Future Cardiac Events in Patients With Systemic Lupus Erythematosus.Cureus. 2023 Oct 16;15(10):e47157. doi: 10.7759/cureus.47157. eCollection 2023 Oct. Cureus. 2023. PMID: 38022274 Free PMC article. Review.
References
-
- Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44:23331–7. - PubMed
-
- Haque S, Bruce IN. Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2005;2:423–30. - PubMed
-
- Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115–26. - PubMed
-
- Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109:2–10. - PubMed
-
- Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003;108:2957–63. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous